{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:26:08Z","timestamp":1792808768827,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Youth Project of Shanxi Province Health Commission","award":["No. 2024036"],"award-info":[{"award-number":["No. 2024036"]}]},{"name":"Key Research Project of Statistical Science in Shanxi Province","award":["No. 2024Z026"],"award-info":[{"award-number":["No. 2024Z026"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-025-02034-8","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:56:00Z","timestamp":1759229760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Genetic variations in amino acid metabolism-related genes are associated with risk of papillary thyroid carcinoma: a case-control study"],"prefix":"10.1186","volume":"25","author":[{"given":"Hongjing","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"10387","key":"2034_CR1","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen DW, Lang BHH, McLeod DSA, Newbold K, Haymart MR. Thyroid cancer. Lancet (London England). 2023;401(10387):1531\u201344.","journal-title":"Lancet (London England)"},{"issue":"11","key":"2034_CR2","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913\u201321.","journal-title":"Cancer Res"},{"issue":"40","key":"2034_CR3","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.2174\/1381612826666200713170047","volume":"26","author":"E Goodarzi","year":"2020","unstructured":"Goodarzi E, Dehkordi AH, Beiranvand R, Naemi H, Khazaei Z. Epidemiology of the incidence and mortality of pancreas cancer and its relationship with the human development index (HDI) in the world: an ecological study in 2018. Curr Pharm Des. 2020;26(40):5163\u201373.","journal-title":"Curr Pharm Des"},{"key":"2034_CR4","doi-asserted-by":"crossref","unstructured":"Araque KA, Gubbi S, Klubo-Gwiezdzinska J. Updates on the management of thyroid cancer. Hormone and metabolic research\u2009=\u2009Hormon- und stoffwechselforschung\u2009=\u2009hormones et metabolisme. 2020;52(8):562\u201377.","DOI":"10.1055\/a-1089-7870"},{"key":"2034_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00082","volume":"11","author":"D Laha","year":"2020","unstructured":"Laha D, Nilubol N, Boufraqech M. New therapies for advanced thyroid cancer. Front Endocrinol. 2020;11:82.","journal-title":"Front Endocrinol"},{"key":"2034_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043274","author":"G Murtas","year":"2023","unstructured":"Murtas G, Pollegioni L. D-amino acids and cancer: friends or foes?? Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24043274.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2034_CR7","first-page":"47","volume":"27","author":"JM Siqueira","year":"2024","unstructured":"Siqueira JM, Vega M, Pimentel GD. Amino acids and cancer: potential for therapies? Curr Opin Clin Nutr Metab Care. 2024;27(1):47\u201354.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"2034_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s12276-020-0375-3","volume":"52","author":"EL Lieu","year":"2020","unstructured":"Lieu EL, Nguyen T, Rhyne S, Kim J. Amino acids in cancer. Exp Mol Med. 2020;52(1):15\u201330.","journal-title":"Exp Mol Med"},{"issue":"2","key":"2034_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ccell.2019.12.011","volume":"37","author":"S Sivanand","year":"2020","unstructured":"Sivanand S, Vander Heiden MG. Emerging roles for branched-chain amino acid metabolism in cancer. Cancer Cell. 2020;37(2):147\u201356.","journal-title":"Cancer Cell"},{"issue":"4","key":"2034_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115529","volume":"44","author":"LK Do","year":"2025","unstructured":"Do LK, Lee HM, Ha YS, Lee CH, Kim J. Amino acids in cancer: understanding metabolic plasticity and divergence for better therapeutic approaches. Cell Rep. 2025;44(4):115529.","journal-title":"Cell Rep"},{"issue":"8","key":"2034_CR11","first-page":"1521","volume":"42","author":"H Qiu","year":"2023","unstructured":"Qiu H, Shao N, Liu J, Zhao J, Chen C, Li Q, et al. Amino acid metabolism in tumor: new shine in the fog? Clinical nutrition (Edinburgh. Scotland). 2023;42(8):1521\u201330.","journal-title":"Scotland)"},{"issue":"2","key":"2034_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s42255-020-00329-9","volume":"3","author":"SL Geeraerts","year":"2021","unstructured":"Geeraerts SL, Heylen E, De Keersmaecker K, Kampen KR. The ins and outs of serine and glycine metabolism in cancer. Nat Metab. 2021;3(2):131\u201341.","journal-title":"Nat Metab"},{"key":"2034_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2021.122729","volume":"235","author":"J Zhang","year":"2021","unstructured":"Zhang J, Wen X, Li Y, Zhang J, Li X, Qian C, et al. Diagnostic approach to thyroid cancer based on amino acid metabolomics in saliva by ultra-performance liquid chromatography with high resolution mass spectrometry. Talanta. 2021;235:122729.","journal-title":"Talanta"},{"issue":"4","key":"2034_CR14","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1158\/1078-0432.CCR-23-2025","volume":"30","author":"YH Kim","year":"2024","unstructured":"Kim YH, Yoon SJ, Kim M, Kim HH, Song YS, Jung JW, et al. Integrative multi-omics analysis reveals different metabolic phenotypes based on molecular characteristics in thyroid cancer. Clin Cancer Res. 2024;30(4):883\u201394.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2034_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02263-4","volume":"24","author":"Y Wan","year":"2025","unstructured":"Wan Y, Li G, Cui G, Duan S, Chang S. Reprogramming of thyroid cancer metabolism: from mechanism to therapeutic strategy. Mol Cancer. 2025;24(1):74.","journal-title":"Mol Cancer"},{"issue":"8","key":"2034_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1850-4","volume":"10","author":"X Zhuang","year":"2019","unstructured":"Zhuang X, Tong H, Ding Y, Wu L, Cai J, Si Y, et al. Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p\/SLC1A5 axis. Cell Death Dis. 2019;10(8):620.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2034_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-0915-8","volume":"14","author":"WY Sun","year":"2016","unstructured":"Sun WY, Kim HM, Jung WH, Koo JS. Expression of serine\/glycine metabolism-related proteins is different according to the thyroid cancer subtype. J Transl Med. 2016;14(1):168.","journal-title":"J Transl Med"},{"issue":"12","key":"2034_CR18","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1007\/s00726-021-03032-5","volume":"53","author":"Y Liu","year":"2021","unstructured":"Liu Y, Mao C, Liu S, Xiao D, Shi Y, Tao Y. Proline dehydrogenase in cancer: apoptosis, autophagy, nutrient dependency and cancer therapy. Amino Acids. 2021;53(12):1891\u2013902.","journal-title":"Amino Acids"},{"issue":"5","key":"2034_CR19","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3803\/EnM.2022.1553","volume":"37","author":"CK Jung","year":"2022","unstructured":"Jung CK, Bychkov A, Kakudo K. Update from the 2022 World Health Organization classification of thyroid tumors: a standardized diagnostic approach. Endocrinol Metab. 2022;37(5):703\u201318.","journal-title":"Endocrinol Metab"},{"issue":"9","key":"2034_CR20","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.7314\/APJCP.2015.16.9.4103","volume":"16","author":"NJ Ge","year":"2015","unstructured":"Ge NJ, Shi ZY, Yu XH, Huang XJ, Wu YS, Chen YY, et al. Genetic variants in ASCT2 gene are associated with the prognosis of transarterial chemoembolisation-treated early- stage hepatocelluar carcinoma. Asian Pac J Cancer Prev. 2015;16(9):4103\u20137.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2034_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/genes15060797","author":"CL Albury","year":"2024","unstructured":"Albury CL, Sutherland HG, Lam AWY, Tran NK, Lea RA, Haupt LM, et al. Identification of polymorphisms in EAAT1 glutamate transporter gene SLC1A3 associated with reduced migraine risk. Genes. 2024. https:\/\/doi.org\/10.3390\/genes15060797.","journal-title":"Genes"},{"issue":"2","key":"2034_CR22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s11033-013-2895-6","volume":"41","author":"M Succi","year":"2014","unstructured":"Succi M, de Castro TB, Galbiatti AL, Arantes LM, da Silva JN, Maniglia JV, et al. DNMT3B C46359T and SHMT1 C1420T polymorphisms in the folate pathway in carcinogenesis of head and neck. Mol Biol Rep. 2014;41(2):581\u20139.","journal-title":"Mol Biol Rep"},{"issue":"3","key":"2034_CR23","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10528-018-9894-1","volume":"57","author":"SZ Nazari Mehrabani","year":"2019","unstructured":"Nazari Mehrabani SZ, Shushizadeh MH, Abazari MF, Nouri Aleagha M, Ardalan A, Abdollahzadeh R, et al. Association of SHMT1, MAZ, ERG, and L3MBTL3 gene polymorphisms with susceptibility to multiple sclerosis. Biochem Genet. 2019;57(3):355\u201370.","journal-title":"Biochem Genet"},{"issue":"1","key":"2034_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11011-017-0128-8","volume":"33","author":"X Guo","year":"2018","unstructured":"Guo X, Tang P, Yang C, Li R. Proline dehydrogenase gene (PRODH) polymorphisms and schizophrenia susceptibility: a meta-analysis. Metab Brain Dis. 2018;33(1):89\u201397.","journal-title":"Metab Brain Dis"},{"key":"2034_CR25","doi-asserted-by":"crossref","unstructured":"Gabriel S, Ziaugra L, Tabbaa D. SNP genotyping using the sequenom massarray iPLEX platform. Curr Protocols Hum Genet. 2009;Chap. 2:Unit 2.12.","DOI":"10.1002\/0471142905.hg0212s60"},{"issue":"2","key":"2034_CR26","first-page":"e131","volume":"8","author":"G Gejoe","year":"2022","unstructured":"Gejoe G, Yadev IP, Kumaran A, Swasthik KS, Chisthi MM. Coexistence of histologically proven chronic lymphocytic thyroiditis with other thyroid disorders: a retrospective study. Surgery journal (New York, NY). 2022;8(2):e131\u20135.","journal-title":"Surgery journal (New York, NY)"},{"issue":"5","key":"2034_CR27","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1530\/EJE-19-0424","volume":"181","author":"H Guan","year":"2019","unstructured":"Guan H, de Morais NS, Stuart J, Ahmadi S, Marqusee E, Kim MI, et al. Discordance of serological and sonographic markers for Hashimoto\u2019s thyroiditis with gold standard histopathology. Eur J Endocrinol. 2019;181(5):539\u201344.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2034_CR28","doi-asserted-by":"publisher","first-page":"862","DOI":"10.17305\/bjbms.2022.7343","volume":"22","author":"Y Chen","year":"2022","unstructured":"Chen Y, Dong B, Huang L, Huang H. Serum microRNAs as biomarkers for the diagnosis of papillary thyroid carcinoma: a meta-analysis. Bosn J Basic Med Sci. 2022;22(6):862\u201371.","journal-title":"Bosn J Basic Med Sci"},{"issue":"2","key":"2034_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cmet.2019.11.020","volume":"31","author":"HC Yoo","year":"2020","unstructured":"Yoo HC, Park SJ, Nam M, Kang J, Kim K, Yeo JH, et al. A variant of SLC1A5 is a mitochondrial glutamine transporter for metabolic reprogramming in cancer cells. Cell Metabol. 2020;31(2):267\u2013. \u2013\u200983.e12.","journal-title":"Cell Metabol"},{"issue":"1","key":"2034_CR30","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41416-019-0637-9","volume":"122","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Liu R, Shuai Y, Huang Y, Jin R, Wang X, et al. ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma. Br J Cancer. 2020;122(1):82\u201393.","journal-title":"Br J Cancer"},{"key":"2034_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158761","author":"G Kim","year":"2022","unstructured":"Kim G, Jang SK, Kim YJ, Jin HO, Bae S, Hong J, et al. Inhibition of glutamine uptake resensitizes Paclitaxel resistance in SKOV3-TR ovarian cancer cell via mTORC1\/S6K signaling pathway. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23158761.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2034_CR32","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s41556-019-0347-9","volume":"21","author":"F Tameire","year":"2019","unstructured":"Tameire F, Verginadis II, Leli NM, Polte C, Conn CS, Ojha R, et al. ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumour progression. Nat Cell Biol. 2019;21(7):889\u201399.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2034_CR33","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/cam4.2689","volume":"9","author":"Y Hara","year":"2020","unstructured":"Hara Y, Minami Y, Yoshimoto S, Hayashi N, Yamasaki A, Ueda S, et al. Anti-tumor effects of an antagonistic mAb against the ASCT2 amino acid transporter on KRAS-mutated human colorectal cancer cells. Cancer Med. 2020;9(1):302\u201312.","journal-title":"Cancer Med"},{"issue":"1","key":"2034_CR34","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1080\/21505594.2022.2112821","volume":"13","author":"P Liu","year":"2022","unstructured":"Liu P, Tang N, Meng C, Yin Y, Qiu X, Tan L, et al. Slc1a3 facilitates Newcastle disease virus replication by regulating glutamine catabolism. Virulence. 2022;13(1):1407\u201322.","journal-title":"Virulence"},{"issue":"1","key":"2034_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.yjmcc.2004.04.008","volume":"37","author":"JC Ralphe","year":"2004","unstructured":"Ralphe JC, Segar JL, Schutte BC, Scholz TD. Localization and function of the brain excitatory amino acid transporter type 1 in cardiac mitochondria. J Mol Cell Cardiol. 2004;37(1):33\u201341.","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"2034_CR36","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-03-j0004.2002","volume":"22","author":"HL Scott","year":"2002","unstructured":"Scott HL, Pow DV, Tannenberg AE, Dodd PR. Aberrant expression of the glutamate transporter excitatory amino acid transporter 1 (EAAT1) in alzheimer\u2019s disease. J Neurosci. 2002;22(3):Rc206.","journal-title":"J Neurosci"},{"issue":"3","key":"2034_CR37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/ajmg.b.30351","volume":"144b","author":"X Deng","year":"2007","unstructured":"Deng X, Shibata H, Takeuchi N, Rachi S, Sakai M, Ninomiya H, et al. Association study of polymorphisms in the glutamate transporter genes SLC1A1, SLC1A3, and SLC1A6 with schizophrenia. Am J Med Genet Part B Neuropsychiatric Genetics: Official Publication Int Soc Psychiatric Genet. 2007;144b(3):271\u20138.","journal-title":"Am J Med Genet Part B Neuropsychiatric Genetics: Official Publication Int Soc Psychiatric Genet"},{"issue":"1","key":"2034_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-020-0993-6","volume":"21","author":"M Ghosh","year":"2020","unstructured":"Ghosh M, Ali A, Joshi S, Srivastava AS, Tapadia MG. SLC1A3 C3590T but not BDNF G196A is a predisposition factor for stress as well as depression, in an adolescent Eastern Indian population. BMC Med Genet. 2020;21(1):53.","journal-title":"BMC Med Genet"},{"issue":"10","key":"2034_CR39","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1002\/ijc.31985","volume":"144","author":"C Corbetta","year":"2019","unstructured":"Corbetta C, Di Ianni N, Bruzzone MG, Patan\u00e8 M, Pollo B, Cantini G, et al. Altered function of the glutamate-aspartate transporter GLAST, a potential therapeutic target in glioblastoma. Int J Cancer. 2019;144(10):2539\u201354.","journal-title":"Int J Cancer"},{"issue":"24","key":"2034_CR40","doi-asserted-by":"publisher","first-page":"14392","DOI":"10.1111\/jcmm.16060","volume":"24","author":"L Xu","year":"2020","unstructured":"Xu L, Chen J, Jia L, Chen X, Awaleh Moumin F, Cai J. SLC1A3 promotes gastric cancer progression via the PI3K\/AKT signalling pathway. J Cell Mol Med. 2020;24(24):14392\u2013404.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"2034_CR41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bbrc.2019.02.023","volume":"511","author":"C Wang","year":"2019","unstructured":"Wang C, Wang Z, Liu W, Ai Z. CD133 promotes the self-renewal capacity of thyroid cancer stem cells through activation of glutamate aspartate transporter SLC1A3 expression. Biochem Biophys Res Commun. 2019;511(1):87\u201391.","journal-title":"Biochem Biophys Res Commun"},{"issue":"21","key":"2034_CR42","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019102147","volume":"38","author":"J Sun","year":"2019","unstructured":"Sun J, Nagel R, Zaal EA, Ugalde AP, Han R, Proost N, et al. SLC1A3 contributes to l-asparaginase resistance in solid tumors. EMBO J. 2019;38(21):e102147.","journal-title":"EMBO J"},{"issue":"10","key":"2034_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165841","volume":"1866","author":"AM Li","year":"2020","unstructured":"Li AM, Ye J. Reprogramming of serine, glycine and one-carbon metabolism in cancer. Biochimica et Biophysica Acta (BBA). 2020;1866(10):165841.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"6","key":"2034_CR44","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/j.1471-4159.2012.07646.x","volume":"120","author":"SJ Hebbring","year":"2012","unstructured":"Hebbring SJ, Chai Y, Ji Y, Abo RP, Jenkins GD, Fridley B, et al. Serine hydroxymethyltransferase 1 and 2: gene sequence variation and functional genomic characterization. J Neurochem. 2012;120(6):881\u201390.","journal-title":"J Neurochem"},{"issue":"1","key":"2034_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1067-5","volume":"38","author":"C Dou","year":"2019","unstructured":"Dou C, Xu Q, Liu J, Wang Y, Zhou Z, Yao W, et al. SHMT1 inhibits the metastasis of HCC by repressing NOX1-mediated ROS production. J Exp Clin Cancer Res. 2019;38(1):70.","journal-title":"J Exp Clin Cancer Res"},{"key":"2034_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13071510","author":"SS Song","year":"2021","unstructured":"Song SS, Huang S, Park S. Association of polygenetic risk scores related to cell differentiation and inflammation with thyroid cancer risk and genetic interaction with dietary intake. Cancers. 2021. https:\/\/doi.org\/10.3390\/cancers13071510.","journal-title":"Cancers"},{"issue":"1","key":"2034_CR47","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12020-021-02827-6","volume":"75","author":"W Ren","year":"2022","unstructured":"Ren W, Xu C, Wang S, Li H, Dai H, Yang F, et al. The effect of VAV3 polymorphisms on thyroid cancer. Endocrine. 2022;75(1):178\u201384.","journal-title":"Endocrine"},{"issue":"4","key":"2034_CR48","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/jcb.22174","volume":"107","author":"J Pandhare","year":"2009","unstructured":"Pandhare J, Donald SP, Cooper SK, Phang JM. Regulation and function of proline oxidase under nutrient stress. J Cell Biochem. 2009;107(4):759\u201368.","journal-title":"J Cell Biochem"},{"issue":"8","key":"2034_CR49","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1158\/1535-7163.MCT-18-1323","volume":"18","author":"GK Scott","year":"2019","unstructured":"Scott GK, Yau C, Becker BC, Khateeb S, Mahoney S, Jensen MB, et al. Targeting mitochondrial proline dehydrogenase with a suicide inhibitor to exploit synthetic lethal interactions with p53 upregulation and glutaminase inhibition. Mol Cancer Ther. 2019;18(8):1374\u201385.","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"2034_CR50","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/biof.1283","volume":"42","author":"I Zareba","year":"2016","unstructured":"Zareba I, Palka J. Prolidase-proline dehydrogenase\/proline oxidase-collagen biosynthesis axis as a potential interface of apoptosis\/autophagy. Biofactors. 2016;42(4):341\u20138.","journal-title":"Biofactors"},{"issue":"1\u20132","key":"2034_CR51","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11010-020-03685-y","volume":"466","author":"TYL Huynh","year":"2020","unstructured":"Huynh TYL, Zareba I, Baszanowska W, Lewoniewska S, Palka J. Understanding the role of key amino acids in regulation of proline dehydrogenase\/proline oxidase (prodh\/pox)-dependent apoptosis\/autophagy as an approach to targeted cancer therapy. Mol Cell Biochem. 2020;466(1\u20132):35\u201344.","journal-title":"Mol Cell Biochem"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02034-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-025-02034-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02034-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:08:59Z","timestamp":1759234139000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-025-02034-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2034"],"URL":"https:\/\/doi.org\/10.1186\/s12902-025-02034-8","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided informed consent, demonstrating their voluntary participation and understanding of the study\u2019s objectives and potential implications. The study was approved by the Ethics Department of Shanxi Provincial People\u2019s Hospital (No. 2018-035) and was conducted in accordance with the World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"214"}}